World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23439
World Ranking
18004
National Ranking
8975

Overview

Stephen C. Rubin is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine, with a particular emphasis on oncology, reproductive medicine, pulmonary and respiratory medicine, surgery, and cardiology and cardiovascular medicine.

The scientist has contributed extensively to the study of ovarian cancer diagnosis and treatment, cardiac, anesthesia and surgical outcomes, renal cell carcinoma treatment, endometrial and cervical cancer treatments, pancreatic and hepatic oncology research, anesthesia and pain management, as well as spine and intervertebral disc pathology.

Frequent co-authors include Christina Chu, Krishnansu S. Tewari, Bradley J. Monk, Joan L. Walker, and Kristin Bixel.

Common publication venues for their work include:

  • Gynecologic Oncology
  • International Journal of Gynecological Cancer
  • Annals of Surgery
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries

Among their recent papers are:

  • Postoperative complications of epidural analgesia at hysterectomy for gynecologic malignancies: an analysis of the National Surgical Quality Improvement Program (2020), International Journal of Gynecological Cancer
  • Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study (2020), Gynecologic Oncology
  • Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study (2021), Gynecologic Oncology
  • A Randomized, Controlled Trial Evaluating Perioperative Risk-stratification and Risk-based, Protocol-driven Management After Elective Major Cancer Surgery (2024), Annals of Surgery
  • Lymph node dissection at the time of hysterectomy for uterine cancer is associated with venous thromboembolism: An analysis of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database (2020), Gynecologic Oncology

Best Publications

  • Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

    Lin Zhang;Jose R. Conejo-Garcia;Dionyssios Katsaros;Phyllis A. Gimotty

  • Regulatory CD4+CD25+ T Cells in Tumors from Patients with Early-Stage Non-Small Cell Lung Cancer and Late-Stage Ovarian Cancer

    Edward Y. Woo;Christina S. Chu;Theresa J. Goletz;Katia Schlienger

  • Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

    M Markman;R Rothman;T Hakes;B Reichman

  • Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

    Robert L. Coleman;Mark F. Brady;Thomas J. Herzog;Paul Sabbatini

  • Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations of BRCA1

    Stephen C. Rubin;Ivor Benjamin;Kian Behbakht;Hiroyuki Takahashi

  • Secondary surgical cytoreduction for advanced ovarian carcinoma

    Peter G Rose;Stacy Nerenstone;Stacy Nerenstone;Mark F Brady;Daniel Clarke-Pearson

  • Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

    William E. Winter;G. Larry Maxwell;Chunqiao Tian;Michael J. Sundborg

  • Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

    M Markman;E Rowinsky;T Hakes;B Reichman

  • Tumor-derived Vascular Endothelial Growth Factor Up-Regulates Angiopoietin-2 in Host Endothelium and Destabilizes Host Vasculature, Supporting Angiogenesis in Ovarian Cancer

    Lin Zhang;Nuo Yang;Jin-Wan Park;Dionyssios Katsaros

  • Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

    Maurie Markman;John Blessing;Stephen C. Rubin;Joseph Connor

  • Mutation Analysis of the BRCA1 Gene in Ovarian Cancers

    Hiroyuki Takahashi;Kian Behbakht;Patricia E. McGovern;Hsiu Chiang Chiu

  • Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

    M Markman;B Reichman;T Hakes;W Jones

  • Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

    Kian Behbakht;Michael W. Sill;Michael W. Sill;Kathleen M. Darcy;Stephen C. Rubin

  • Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer.

    Lin Zhang;Nuo Yang;Alisha Mohamed-Hadley;Stephen C Rubin

  • BRCA1, BRCA2, and Hereditary Nonpolyposis Colorectal Cancer Gene Mutations in an Unselected Ovarian Cancer Population: Relationship to Family History and Implications for Genetic Testing

    Stephen C. Rubin;M. Anne Blackwood;Christina Bandera;Kian Behbakht

  • Vascular leukocytes contribute to tumor vascularization.

    Jose R. Conejo-Garcia;Ronald J. Buckanovich;Fabian Benencia;Maria C. Courreges

  • Prevalence and Predictors of Psychological Distress Among Women With Ovarian Cancer

    Tina R. Norton;Sharon L. Manne;Stephen Rubin;John Carlson

  • Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

    Joan L. Walker;Mark F. Brady;Lari Wenzel;Gini F. Fleming

  • Treatment of endometrial stromal tumors

    Andrew Berchuck;Stephen C. Rubin;William J. Hoskins;Patricia E. Saigo

  • Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.

    Stephen C. Rubin;Thomas C. Randall;Katrina A. Armstrong;Dennis S. Chi

Frequent Co-Authors

William J. Hoskins
William J. Hoskins Memorial Sloan Kettering Cancer Center
Maurie Markman
Maurie Markman The University of Texas MD Anderson Cancer Center
George Coukos
George Coukos Cornell University
Richard R. Barakat
Richard R. Barakat Northwell Health
Kenneth O. Lloyd
Kenneth O. Lloyd Memorial Sloan Kettering Cancer Center
Lin Zhang
Lin Zhang University of Pennsylvania
Robert S. Mannel
Robert S. Mannel University of Oklahoma Health Sciences Center
Sharon L. Manne
Sharon L. Manne Rutgers, The State University of New Jersey
Phyllis A. Gimotty
Phyllis A. Gimotty University of Pennsylvania
Virginia A. LiVolsi
Virginia A. LiVolsi University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is highly competitive and rigorous, prospective healthcare professionals have alternative pathways to build their careers. Online nursing programs offer flexible, accredited options for students seeking practical, in-demand healthcare roles.

For those looking to start their nursing journey or advance their credentials, a nursing degree online provides a convenient and often more affordable entry point. Registered nurses aiming to expand their skills and earning potential can pursue cheap rn to bsn online programs, designed to fit around busy work schedules.

For non-nurses or career changers, cheapest direct entry msn programs allow individuals with a non-nursing bachelor’s degree to become nurses with a master’s qualification in an accelerated timeframe. Practicing nurses aiming to reach the highest clinical positions may consider the cheapest online dnp programs for terminal professional degrees.

These online degrees create flexible and cost-effective career pathways, helping students unlock new opportunities in healthcare without the traditional roadblocks of location, time, or steep tuition costs.

Best Scientists Citing Stephen C. Rubin

Trending Scientists

Recently Published Articles